SPRING BANK PHARMACEUTICALS (SBPH) analyst actions
Rating and price-target actions on SBPH in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SBPH overview →
No SBPH analyst action events in the measured window.
Nothing matched in the current window — the SBPH overview has every event we measure for this name.
Get an email when SBPH moves on news →Keep exploring
More SBPH: earnings → · SEC filings → · SBPH overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| NeoGenomics, Inc. (NEO) | 406 | -0.22% | 44% |
| Vericel Corporation (VCEL) | 406 | -0.19% | 40% |
| AKCEA THERAPEUTICS (AKCA) | 401 | 0.00% | 49% |
| Blueprint Medicines Corporation (BPMC) | 401 | -0.03% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.